The content of DNA and oestradiol receptors was measured in two different samples taken from the same tumoral mass of 33 primary infiltrating ductal carcinomas. The results were related to the total cytoplasmic protein and to the DNA of the tissue. The results showed that variations of both DNA and oestradiol receptors are frequent and often significant. The reliability of analyses carried out on a single biopsy is discussed.
Get full access to this article
View all access options for this article.
References
1.
BraunsbergH.: Oestrogen receptors in relation to human breast cancer.Res. Clin. Lab.,8: 47–74, 1977.
2.
BraunsbergH.: Factors influencing the estimation of estrogen receptors in human malignant breast tumors.Eur. J. Cancer,11: 499–512, 1975.
3.
BurtonK.: A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.Biochem. J.,62: 315–323, 1956.
4.
ChesterZ., FehertyP., KellieA.E., RalpheD.N.L.: Estrogen receptors in primary breast tumors in relation to the stage and progression of the disease. In: Estrogen Receptors in Human Breast Cancer. pp. 157–172. McGuireW.L., CarboneP.P., VollmerE.P. (eds.). Raven Press, New York, 1975.
5.
Di FronzoG., BertuzziA., RonchiE.: An improved criterion for the evaluation of estrogen receptor binding data in human breast cancer.Tumori,64: 259–266, 1978.
6.
E.O.R.T.C. Breast Cancer Cooperative Group:Standards for the assessment of estrogen receptors in human breast cancer.Eur. J. Cancer,9: 379–381, 1973.
7.
HawkinsR.A., HillA., FreedmanB., GoreS.M., RobertsM.M., ForrestA.P.M.: Reproducibility of measurements of oestrogen receptor concentration in breast cancer.Br. J. Cancer,36: 355–361, 1977.
8.
JensenE.V., BlockG.E., SmithS., De SombreE.R.: Estrogen receptors and breast cancer response to adrenalectomy.Natl. Cancer Inst. Monogr.,34: 55–79, 1971.
9.
KendallM.: The measurement of Rank correlation. In: Rank Correlation Methods. pp. 1–18. C. Griffin and Co. Ltd., London, 1975.
10.
KiangD.T., KennedyB.J.: Factors affecting estrogen receptors in breast cancer.Cancer,40: 1571–1576, 1977.
11.
LowryO.H., RosebroughN.J., FarrA.L., RandallR.J.: Protein measurement with the Folin phenol reagent.J. Biol. Chem.,193: 265–275, 1951.
12.
MastersJ.R.W., HawkinsR.A., SangsterK., HawkinsW., SmithI.I., ShivasA.A., RobertsM.M., ForrestA.P.M.: Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer.Eur. J. Cancer,14: 303–307, 1978.
13.
McGuireW.L., CarboneP.P., SearsM.E., EscherG.C.: Estrogen receptors in human breast cancer: An overview. In: Estrogen Receptors in Human Breast Cancer. pp. 1–8. McGuireW.L., CarboneP.P., VollmerE.P. (eds.). Raven Press, New York, 1975.
14.
ScatchardG.: The attraction of protein for small molecules and ions. Ann. N.Y.Acad. Sci.,51: 660–672, 1949.
15.
WebbJ.M., LindstromH.V.: Acid solubilization of animal tissue nucleic acids as related to their extraction and estimation.Arch. Biochem. Biophys.,112: 273–281, 1965.
16.
WittliffJ.L., SarlovE.D.: Estrogen-binding capacity of cytoplasmic forms of the estrogen receptors in human breast cancer. In: Estrogen Receptors in Human Breast Cancer. pp. 73–93. McGuireW.L., CarboneP.P., VollmerE.P. (eds.). Raven Press, New York, 1975.
